Overview
This is a prospective, open-label clinical study designed to evaluate the performance and safety of the ORYOM Robotic Surgical System during cataract surgery.
Eligibility
Main Inclusion Criteria:
- Patient aged 55 to 80 years
- Willing and able to sign an informed consent, attend the clinic and comply with all study procedures and the study protocol
- Patients are scheduled to undergo cataract surgery
- Clear intraocular media, other than cataract
- Pupil dilate according to stand of care
Main Exclusion Criteria:
- Prior ocular surgery or trauma in the study eye
- Polar cataract in the study eye
- Zonular instability or significant anterior segment abnormalities
- Active ocular infection or uveitis
- Pseudoexfoliation (PXF) syndrome in either eye
- ASA Physical Status Classification \> 3
- Participation in another clinical trial within 30 days
